What is the address of Jean Radermacher Société Médicale?

The registered office of Jean Radermacher Société Médicale is located at Quai de la Boverie 25, 4020 Liège.

Is Jean Radermacher Société Médicale still active?

Yes. According to the CBE (3 October 2026) Jean Radermacher Société Médicale is active, legal situation “Normale toestand”, started on 25 January 2022.

Is Jean Radermacher Société Médicale registered on Peppol?

Yes, Jean Radermacher Société Médicale is registered on the Peppol network with ID 0208:0780841387.

What is the enterprise number of Jean Radermacher Société Médicale?

The enterprise number of Jean Radermacher Société Médicale is BE0780841387.

When was Jean Radermacher Société Médicale founded?

Jean Radermacher Société Médicale was founded on 25 January 2022.

Who are the directors of Jean Radermacher Société Médicale?

According to the 2025 annual accounts, the directors of Jean Radermacher Société Médicale are: Jean RADERMACHER.

Is Jean Radermacher Société Médicale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 January 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Jean Radermacher Société Médicale make in 2025?

Jean Radermacher Société Médicale posted a profit after taxes of € 518,955 in financial year 2025.

What is the revenue of Jean Radermacher Société Médicale?

As a small company, Jean Radermacher Société Médicale is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 713,337.

Jean Radermacher Société Médicale (Private Limited)

Dossier Jean Radermacher Société Médicale, printed on 3 October 2026 from databakkes.be/en/0780841387/jean-radermacher-societe-medicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Jean Radermacher Société Médicale from Liège, company number BE0780841387, closed financial year 2025 with a result of € 518,955 after tax. For that financial year Jean Radermacher Société Médicale recorded a gross margin of € 713,337 and equity of € 400,910. Compared with financial year 2024, the result moved from € 170,253 to € 518,955. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Healthy

€ 400,910

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 518,955

▲ 205% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 727,233

▲ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 550,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 28,065

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 24,572

▼ 31% vs 2024

€ 11,484 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 601

▲ 62% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 140,314

▲ 162% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 151,457 Gross margin 2022: € 151,457 First fiscal year in the series	€ 332,729 Gross margin 2023: € 332,729 ▲ 120% vs 2022 (€ 151,457) Favourable step	€ 236,661 Gross margin 2024: € 236,661 ▼ 29% vs 2023 (€ 332,729) Unfavourable step	€ 713,337 Gross margin 2025: € 713,337 ▲ 201% vs 2024 (€ 236,661) Favourable step	▲ 201%
Profit after taxes	€ 116,415 Profit after taxes 2022: € 116,415 First fiscal year in the series	€ 242,720 Profit after taxes 2023: € 242,720 ▲ 108% vs 2022 (€ 116,415) Favourable step	€ 170,253 Profit after taxes 2024: € 170,253 ▼ 30% vs 2023 (€ 242,720) Unfavourable step	€ 518,955 Profit after taxes 2025: € 518,955 ▲ 205% vs 2024 (€ 170,253) Favourable step	▲ 205%
Equity	€ 120,615 Equity 2022: € 120,615 First fiscal year in the series	€ 362,535 Equity 2023: € 362,535 ▲ 201% vs 2022 (€ 120,615) Favourable step	€ 431,955 Equity 2024: € 431,955 ▲ 19% vs 2023 (€ 362,535) Favourable step	€ 400,910 Equity 2025: € 400,910 ▼ 7% vs 2024 (€ 431,955) Unfavourable step	▼ 7%
Total debts	€ 38,990 Total debts 2022: € 38,990 First fiscal year in the series	€ 125,458 Total debts 2023: € 125,458 ▲ 222% vs 2022 (€ 38,990) Unfavourable step	€ 190,208 Total debts 2024: € 190,208 ▲ 52% vs 2023 (€ 125,458) Unfavourable step	€ 716,811 Total debts 2025: € 716,811 ▲ 277% vs 2024 (€ 190,208) Unfavourable step	▲ 277%
Cash	€ 91,161 Cash 2022: € 91,161 First fiscal year in the series	€ 258,735 Cash 2023: € 258,735 ▲ 184% vs 2022 (€ 91,161) Favourable step	€ 499,976 Cash 2024: € 499,976 ▲ 93% vs 2023 (€ 258,735) Favourable step	€ 727,233 Cash 2025: € 727,233 ▲ 45% vs 2024 (€ 499,976) Favourable step	▲ 45%
Retained profit	€ 115,615 Retained profit 2022: € 115,615 First fiscal year in the series	€ 357,535 Retained profit 2023: € 357,535 ▲ 209% vs 2022 (€ 115,615) Favourable step	€ 426,955 Retained profit 2024: € 426,955 ▲ 19% vs 2023 (€ 357,535) Favourable step	€ 395,910 Retained profit 2025: € 395,910 ▼ 7% vs 2024 (€ 426,955) Unfavourable step	▼ 7%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 800 Dividend 2023: € 800 Unchanged (€ 800) Unchanged	€ 100,833 Dividend 2024: € 100,833 ▲ € 100,033 vs 2023 (€ 800) Unchanged	€ 550,000 Dividend 2025: € 550,000 ▲ € 449,167 vs 2024 (€ 100,833) Unchanged	▲ € 449,167
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 45,928 Bank debt 2023: € 45,928 Unchanged (€ 0) Unfavourable step	€ 35,510 Bank debt 2024: € 35,510 ▼ 23% vs 2023 (€ 45,928) Favourable step	€ 24,572 Bank debt 2025: € 24,572 ▼ 31% vs 2024 (€ 35,510) Favourable step	▼ 31%
Balance sheet total	€ 159,605 Balance sheet total 2022: € 159,605 First fiscal year in the series	€ 487,993 Balance sheet total 2023: € 487,993 ▲ 206% vs 2022 (€ 159,605) Unchanged	€ 622,163 Balance sheet total 2024: € 622,163 ▲ 27% vs 2023 (€ 487,993) Unchanged	€ 1,117,721 Balance sheet total 2025: € 1,117,721 ▲ 80% vs 2024 (€ 622,163) Unchanged	▲ 80%

Key figures of Jean Radermacher Société Médicale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Jean Radermacher Société Médicale?

What happened at Jean Radermacher Société Médicale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 518,955 (▲ 205% vs 2024). filed late Source: NBB ↗
Jan 25, 2022 New establishment in Liège. KBO
Jan 25, 2022 Start of the company according to the CBE. KBO
2022 Jean RADERMACHER became a director. NBB

In short

From € 116,415 profit in 2022 to € 518,955 profit in 2025.

Paid € 335,535 in corporate taxes since 2022.

Best year ever: 2025, with € 518,955 profit.

Paid out € 652,433 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Jean Radermacher Société Médicale? We notify you, reason included.

Follow Jean Radermacher Société Médicale

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jean RADERMACHER

Jean Radermacher Société Médicale

Behind Jean Radermacher Société Médicale is Jean RADERMACHER.

See the full network in the app

Directors

According to the 2025 annual accounts

Jean RADERMACHER

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Quai de la Boverie 25

4020 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0780.841.387
VAT number: BE 0780.841.387
Registered office: Quai de la Boverie 25, 4020 Liège
Names & denominations: Jean Radermacher Société Médicale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 January 2022
Peppol: Active · Active since 8 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗